The Journal of Nuclear Medicine (ISSN 0161-5505) is a distinguished monthly peer-reviewed publication based in the United States, issued by the Society of Nuclear Medicine and Molecular Imaging (SNMMI). As a leading venue in the field, it consistently maintains a high impact factor and is indexed in the Science Citation Index (SCI), frequently ranking within the top tier of the Chinese Academy of Sciences journal classification for medical and nuclear medicine disciplines. The journal focuses on cutting-edge research in nuclear medicine and molecular imaging, with a particular emphasis on the development of radiopharmaceuticals, advancements in imaging technologies, and clinical applications in disease diagnosis and therapy. It places significant weight on translational research that bridges the gap between fundamental science and clinical practice. While the journal is not open access, which may limit immediate free access for some readers, it is widely recognized for its rigorous peer-review process, high academic standards, and strong reputation within the global scientific community. Consequently, the publication process is highly competitive, characterized by a substantial rejection rate and potentially high article processing charges, reflecting the journal’s commitment to disseminating only the most impactful and high-quality work in the field.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com